Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
AssigneeThe Rockefeller University
InventorsHerminia de Lencastre, Alexander Tomasz
Life of this patent
Estimating the term…
Abstract
The present invention is directed to the identification of mutant strains of methicillin resistant bacteria, in particular methicillin resistant Staphylococcus aureus, to identify the characteristics of such bacteria and develop drugs that can reverse, inhibit, or reduce bacterial resistance to beta lactam antibiotics, e.g., methicillin. The invention particularly relates to identification of a novel mutant strain of methicillin resistant S. aureus that manifests a unique phenotype. Accordingly, the invention provides for methods of treatment and corresponding pharmaceutical compositions for treating bacterial, particularly staphylococcal, infections.
Claims13
An isolated polynucleotide fragment selected from the group consisting of
- (a) a polynucleotide fragment consisting of the polynucleotide of SEQ ID No:1;
- (b) a polynucleotide fragment consisting of residues 2210 to 3634 of SEQ ID No:1;
- and
- (c) a polynucleotide fragment consisting of a coding region encoding the polypeptide of SEQ ID No:2.
A mutant Staphylococcus aureus strain characterized by:
- a) increased sensitivity to an antibiotic to which a parent of the mutant strain is resistant;
- and
- b) location of the mutation in the murE gene which encodes the protein UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase.
An isolated polynucleotide fragment consisting of the coding region from the Staphylococcus aureus murE gene which encodes a UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase.
An isolated polynucleotide fragment consisting of a coding sequence encoding a polypeptide having UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase activity wherein said fragment hybridizes to the polynucleotide of SEQ ID No:1 in 50% formamide at 42° C.
Dependencies are inferred from the claim text.